Bumrungrad International Hospital continues its commitment to elevating the quality of medical care through international quality accreditation by the Joint Commission International Clinical Care Program Certification (JCI CCPC), a global organization based in the United States that assesses the quality and safety of hospitals worldwide.
Bumrungrad International Hospital was the first private hospital in Asia to be accredited by JCI and has since been continuously re-accredited. Recently, the Bumrungrad Heart Institute’s Heart Failure Program received its re-accreditation, while the Bumrungrad Breast Center’s Breast Cancer Program earned its first accreditation. This marks a significant international achievement, as only around 400 hospitals globally have received certification under this program—with the Bumrungrad Breast Center being one of the few located outside the United States.
Barry Wolfman, Senior Executive Director of Operations of Bumrungrad International Hospital, stated, “It is a great honor that our Heart Institute and Breast Center have received international recognition from the JCI CCPC. This reflects our unwavering commitment, dedication, and precision, as well as the outstanding teamwork of our physicians and clinical staff. Together, we strive to deliver truly patient-centered care, upholding the highest standards in quality, safety, and clinical excellence—the core values that define the true essence of Bumrungrad.”
These achievements further affirm Bumrungrad’s status as one of Newsweek’s Top 100 World’s Best Hospitals 2025—and, most importantly, reinforce the trust and confidence patients continue to place in the hospital.
“We choose to do this not because we have to, but because we believe in doing better,” Mr. Wolfman concluded.
Bumrungrad International Hospital is committed to delivering high-quality, safe, and compassionate care to create a lasting, meaningful difference in the lives of every patient.